Top broker gives its verdict on the Nanosonics (ASX:NAN) share price

A new product launch has been announced. Does this make it a buy?

| More on:
digitised image of line chart together with covid bugs signifying asx 200 healthcare shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price was out of form on Monday despite announcing a new product launch.

The infection prevention company's shares fell over 2% to $5.84.

What did Nanosonics announce?

After years of promising new product launches, Nanosonics has announced a new product called AuditPro.

AuditPro is a digital platform that has been designed to improve traceability, reporting, and compliance of infection prevention measures for medical devices.

The first application will focus on a solution for the ultrasound market, with potential for the new product to be coupled with every ultrasound console at point of care. This complements its industry leading Trophon EPR disinfection system for ultrasound probes.

Management notes that the product will generate new revenue streams associated with a mobile scanning device and subscription-based software that provides real time access for customers to necessary infection prevention compliance data.

Does this make the Nanosonics share price good value?

Analysts at Goldman Sachs have been looking over the new product and have given their verdict.

Goldman said: "Whilst we do not expect the direct revenue streams to be material in the initial year(s), we expect an indirect benefit from the potential to drive adoption of trophon2 (including upgrades from trophon EPR since AuditPro will only be compatible with the newer platform). As a device which actively encourages HLD utilisation, it may also be effective at improving the demand for consumables."

And while this is positive, it isn't enough for a change of rating just yet. Goldman continues to believe that the Nanosonics share price is fully valued at the current level.

In light of this, the broker has retained its neutral rating and $5.30 price target. This compares to the latest Nanosonics share price of $5.84.

Though, it has hinted that it will reconsider its recommendation when further R&D updates are released.

Goldman explained: "Management stated that further R&D updates will be provided throughout FY22E (we will look for further colour at the FY21 earnings announcement in mid-August). We expect updates/views on these new products to be a large focus of the market over the coming quarters."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Morgans says these ASX shares can rise 20% to 45%

Let's see why the broker is bullish on these shares.

Read more »

Workers inspecting a gas pipeline.
Broker Notes

What's Macquarie's price target for Origin Energy shares?

Could Origin be primed for a turnaround?

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Bank building in a financial district.
Bank Shares

Which is the only ASX 200 bank stock Macquarie expects to outperform in FY 2026?

Macquarie forecasts a tough year ahead for the ASX 200 banks, with only one expected to outperform.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These ASX 200 shares could rise 30% to 50%

Brokers have good things to say about these cheap shares.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

10 Aussie stocks to buy in FY 2026

Let's see which shares analysts think could be buys in the upcoming financial year.

Read more »

watch
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »